| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Molecular and Cell Biology and The Cancer Research Laboratory [C. M. C., S. J. H., E. J. C., G. L. F.] and Department of Nutritional Sciences [C. H., J. E. R., L. F. B.], The University of California at Berkeley, Berkeley, California 94720-3200
ABSTRACT
The current options for treating breast cancer are limited to excision surgery, general chemotherapy, radiation therapy, and, in a minority of breast cancers that rely on estrogen for their growth, antiestrogen therapy. The naturally occurring chemical indole-3-carbinol (I3C), found in vegetables of the Brassica genus, is a promising anticancer agent that we have shown previously to induce a G1 cell cycle arrest of human breast cancer cell lines, independent of estrogen receptor signaling. Combinations of I3C and the antiestrogen tamoxifen cooperate to inhibit the growth of the estrogen-dependent human MCF-7 breast cancer cell line more effectively than either agent alone. This more stringent growth arrest was demonstrated by a decrease in adherent and anchorage-independent growth, reduced DNA synthesis, and a shift into the G1 phase of the cell cycle. A combination of I3C and tamoxifen also caused a more pronounced decrease in cyclin-dependent kinase (CDK) 2-specific enzymatic activity than either compound alone but had no effect on CDK2 protein expression. Importantly, treatment with I3C and tamoxifen ablated expression of the phosphorylated retinoblastoma protein (Rb), an endogenous substrate for the G1 CDKs, whereas either agent alone only partially inhibited endogenous Rb phosphorylation. Several lines of evidence suggest that I3C works through a mechanism distinct from tamoxifen. I3C failed to compete with estrogen for estrogen receptor binding, and it specifically down-regulated the expression of CDK6. These results demonstrate that I3C and tamoxifen work through different signal transduction pathways to suppress the growth of human breast cancer cells and may, therefore, represent a potential combinatorial therapy for estrogen-responsive breast cancer.
This article has been cited by other articles:
|
|
 |
|
  S. Ali, S. Banerjee, A. Ahmad, B. F. El-Rayes, P. A. Philip, and F. H. Sarkar Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer Mol. Cancer Ther., June 1, 2008; 7(6): 1708 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang, B. W. Yu, K. W. Rahman, F. Ahmad, and F. H. Sarkar Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip Mol. Cancer Ther., February 1, 2008; 7(2): 341 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Rahman, S. Ali, A. Aboukameel, S. H. Sarkar, Z. Wang, P. A. Philip, W. A. Sakr, and A. Raz Inactivation of NF-{kappa}B by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells Mol. Cancer Ther., October 1, 2007; 6(10): 2757 - 2765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-R. Weng, C.-H. Tsai, S. K. Kulp, D. Wang, C.-H. Lin, H.-C. Yang, Y. Ma, A. Sargeant, C.-F. Chiu, M.-H. Tsai, et al. A Potent Indole-3-Carbinol Derived Antitumor Agent with Pleiotropic Effects on Multiple Signaling Pathways in Prostate Cancer Cells Cancer Res., August 15, 2007; 67(16): 7815 - 7824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Sundar, V. Kerekatte, C. N. Equinozio, V. B. Doan, L. F. Bjeldanes, and G. L. Firestone Indole-3-Carbinol Selectively Uncouples Expression and Activity of Estrogen Receptor Subtypes in Human Breast Cancer Cells Mol. Endocrinol., December 1, 2006; 20(12): 3070 - 3082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yu, B. Mahadevan, C. V. Lohr, K. A. Fischer, M. A. Louderback, S. K. Krueger, C. B. Pereira, D. J. Albershardt, W. M. Baird, G. S. Bailey, et al. Indole-3-carbinol in the maternal diet provides chemoprotection for the fetus against transplacental carcinogenesis by the polycyclic aromatic hydrocarbon dibenzo[a,l]pyrene Carcinogenesis, October 1, 2006; 27(10): 2116 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Sarkar and Y. Li Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res., April 1, 2006; 66(7): 3347 - 3350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chang, G. L. Firestone, and L. F. Bjeldanes Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane Carcinogenesis, March 1, 2006; 27(3): 541 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Prathapam, S. Tegen, T. Oskarsson, A. Trumpp, and G. S. Martin Activated Src abrogates the Myc requirement for the G0/G1 transition but not for the G1/S transition PNAS, February 21, 2006; 103(8): 2695 - 2700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Brandi, G. F. Schiavano, N. Zaffaroni, C. De Marco, M. Paiardini, B. Cervasi, and M. Magnani Mechanisms of Action and Antiproliferative Properties of Brassica oleracea Juice in Human Breast Cancer Cell Lines J. Nutr., June 1, 2005; 135(6): 1503 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Garcia, G. A. Brar, D. H. H. Nguyen, L. F. Bjeldanes, and G. L. Firestone Indole-3-Carbinol (I3C) Inhibits Cyclin-dependent Kinase-2 Function in Human Breast Cancer Cells by Regulating the Size Distribution, Associated Cyclin E Forms, and Subcellular Localization of the CDK2 Protein Complex J. Biol. Chem., March 11, 2005; 280(10): 8756 - 8764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Rahman and F. H. Sarkar Inhibition of Nuclear Translocation of Nuclear Factor-{kappa}B Contributes to 3,3'-Diindolylmethane-Induced Apoptosis in Breast Cancer Cells Cancer Res., January 1, 2005; 65(1): 364 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Neave, S. M. Sarup, M. Seidelin, F. Duus, and O. Vang Characterization of the N-methoxyindole-3-carbinol (NI3C)-Induced Cell Cycle Arrest in Human Colon Cancer Cell Lines Toxicol. Sci., January 1, 2005; 83(1): 126 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Sarkar and Y. Li Indole-3-Carbinol and Prostate Cancer J. Nutr., December 1, 2004; 134(12): 3493S - 3498S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Chatterji, J. E. Riby, T. Taniguchi, E. L. Bjeldanes, L. F. Bjeldanes, and G. L. Firestone Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells Carcinogenesis, July 1, 2004; 25(7): 1119 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Fulop Integrative Tumor Board: Recurrent Breast Cancer or New Primary? Integr Cancer Ther, September 1, 2003; 2(3): 276 - 283. [PDF]
|
|
|
|
|
|
G. Brandi, M. Paiardini, B. Cervasi, C. Fiorucci, P. Filippone, C. De Marco, N. Zaffaroni, and M. Magnani A New Indole-3-Carbinol Tetrameric Derivative Inhibits Cyclin-dependent Kinase 6 Expression, and Induces G1 Cell Cycle Arrest in Both Estrogen-dependent and Estrogen-independent Breast Cancer Cell Lines Cancer Res., July 15, 2003; 63(14): 4028 - 4036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Sarkar, K. M. W. Rahman, and Y. Li Bax Translocation to Mitochondria Is an Important Event in Inducing Apoptotic Cell Death by Indole-3-Carbinol (I3C) Treatment of Breast Cancer Cells J. Nutr., July 1, 2003; 133(7): 2434S - 2439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Firestone and L. F. Bjeldanes Indole-3-Carbinol and 3-3'-Diindolylmethane Antiproliferative Signaling Pathways Control Cell-Cycle Gene Transcription in Human Breast Cancer Cells by Regulating Promoter-Sp1 Transcription Factor Interactions J. Nutr., July 1, 2003; 133(7): 2448S - 2455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Howells, B. Gallacher-Horley, C. E. Houghton, M. M. Manson, and E. A. Hudson Indole-3-carbinol Inhibits Protein Kinase B/Akt and Induces Apoptosis in the Human Breast Tumor Cell Line MDA MB468 but not in the Nontumorigenic HBL100 Line Mol. Cancer Ther., November 1, 2002; 1(13): 1161 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. BRADLOW and D. W. SEPKOVIC Diet and Breast Cancer Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 247 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Larsen-Su and D. E. Williams Transplacental Exposure to Indole-3-carbinol Induces Sex-Specific Expression of CYP1A1 and CYP1B1 in the Liver of Fischer 344 Neonatal Rats Toxicol. Sci., December 1, 2001; 64(2): 162 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bagheri-Yarmand, Y. Hamma-Kourbali, P. Bissieres, J.-F. Morere, and M. Crepin Carboxymethyl Benzylamide Dextran and Tamoxifen Combination Inhibits Tumor Growth and Angiogenesis Clin. Cancer Res., June 1, 2001; 7(6): 1805 - 1811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Meng, F. Yuan, I. D. Goldberg, E. M. Rosen, K. Auborn, and S. Fan Indole-3-Carbinol Is a Negative Regulator of Estrogen Receptor-{{alpha}} Signaling in Human Tumor Cells J. Nutr., December 1, 2000; 130(12): 2927 - 2931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fiorentino, A. Altimari, A. D’Errico, B. Cukor, C. Barozzi, M. Loda, and W. F. Grigioni Acquired Expression of p27 Is a Favorable Prognostic Indicator in Patients with Hepatocellular Carcinoma Clin. Cancer Res., October 1, 2000; 6(10): 3966 - 3972. [Abstract] [Full Text]
|
|
|
|
|
|
H. L. BRADLOW, D. W. SEPKOVIC, N. T. TELANG, and M. P. OSBORNE Multifunctional Aspects of the Action of Indole-3-Carbinol as an Antitumor Agent Ann. N.Y. Acad. Sci., January 1, 1999; 889(1): 204 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Cram, B. D. Liu, L. F. Bjeldanes, and G. L. Firestone Indole-3-carbinol Inhibits CDK6 Expression in Human MCF-7 Breast Cancer Cells by Disrupting Sp1 Transcription Factor Interactions with a Composite Element in the CDK6 Gene Promoter J. Biol. Chem., June 15, 2001; 276(25): 22332 - 22340. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
